I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Irurzun-Arana, Itziar
32
results:
Search for persons
X
Format
Online (32)
Mediatypes
Articles (Online) (14)
OpenAccess-fulltext (18)
Sorted by: Relevance
Sorted by: Year
?
1
Phase II study of ceralasertib (AZD6738) in combination wit..:
Kwon, Minsuk
;
Kim, Gahyun
;
Kim, Ryul
...
Journal for ImmunoTherapy of Cancer. 10 (2022) 7 - p. e005041 , 2022
Link:
https://doi.org/10.1136/..
?
2
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Co..:
Yap, Timothy A.
;
Krebs, Matthew G.
;
Postel-Vinay, Sophie
...
Clinical Cancer Research. 27 (2021) 19 - p. 5213-5224 , 2021
Link:
https://doi.org/10.1158/..
?
3
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage..:
Kim, Seung Tae
;
Smith, Simon A.
;
Mortimer, Peter
...
Clinical Cancer Research. 27 (2021) 17 - p. 4700-4709 , 2021
Link:
https://doi.org/10.1158/..
?
4
Investigational Treatments for COVID‐19 may Increase Ventri..:
Varshneya, Meera
;
Irurzun-Arana, Itziar
;
Campana, Chiara
...
CPT: Pharmacometrics & Systems Pharmacology. 10 (2021) 2 - p. 100-107 , 2021
Link:
https://doi.org/10.1002/..
?
5
Beyond Deterministic Models in Drug Discovery and Developme..:
Irurzun-Arana, Itziar
;
Rackauckas, Christopher
;
McDonald, Thomas O.
.
Trends in Pharmacological Sciences. 41 (2020) 11 - p. 882-895 , 2020
Link:
https://doi.org/10.1016/..
?
6
Predicting circulating biomarker response and its impact on..:
Irurzun-Arana, Itziar
;
Asín-Prieto, Eduardo
;
Martín-Algarra, Salvador
.
Scientific Reports. 10 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1038/..
?
7
Optimal dynamic control approach in a multi-objective thera..:
Irurzun-Arana, Itziar
;
Janda, Alvaro
;
Ardanza-Trevijano, Sergio
..
PLOS Computational Biology. 14 (2018) 4 - p. e1006087 , 2018
Link:
https://doi.org/10.1371/..
?
8
A systems pharmacology model for inflammatory bowel disease:
Balbas-Martinez, Violeta
;
Ruiz-Cerdá, Leire
;
Irurzun-Arana, Itziar
...
PLOS ONE. 13 (2018) 3 - p. e0192949 , 2018
Link:
https://doi.org/10.1371/..
?
9
Advanced Boolean modeling of biological networks applied to..:
Irurzun-Arana, Itziar
;
Pastor, José Martín
;
Trocóniz, Iñaki F
..
Bioinformatics. 33 (2017) 7 - p. 1040-1048 , 2017
Link:
https://doi.org/10.1093/..
?
10
Towards patient stratification and treatment in the autoimm..:
Ruiz-Cerdá, M. Leire
;
Irurzun-Arana, Itziar
;
González-Garcia, Ignacio
...
European Journal of Pharmaceutical Sciences. 94 (2016) - p. 46-58 , 2016
Link:
https://doi.org/10.1016/..
?
11
Phase II study of ceralasertib (AZD6738) in combination wit..:
Kwon, Minsuk
;
Kim, Gahyun
;
Kim, Ryul
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258491/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
12
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Co..:
Yap, Timothy A
;
Krebs, Matthew G
;
Postel-Vinay, Sophie
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401487/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
13
Investigational Treatments for COVID-19 May Increase Ventri..:
Varshneya, Meera
;
Irurzun-Arana, Itziar
;
Campana, Chiara
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879810/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
14
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage..:
Kim, Seung Tae
;
Smith, Simon A
;
Mortimer, Peter
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974415/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
15
Investigational treatments for COVID-19 may increase ventri..:
Varshneya, Meera
;
Irurzun-Arana, Itziar
;
Campana, Chiara
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273296/. , 2020
Link:
http://www.ncbi.nlm.nih...
1-15
